These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2004-004181-32||FOLFOX 4 + CETUXIMAB IN UNTREATED PATIENTS WITH ADVANCED COLO-RECTAL TUMOUR. A PHASE II MULTICENTER STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE||bad-data|
|Ongoing||2005-002181-11||FOLFIRI vs XELIRI in the treatment of advanced colo-rectal untreated carcinoma: a phase II randomized study of the Gruppo Oncologico dell'Italia Meridionale||not-yet-due|
|Ongoing||2006-002737-21||A randomized phase II study in the advanced or metastatic transitional cell urotelium carcinoma between Gemcitabine + Cisplatin e Gemcitabine + Cisplatino + Taxolo||not-yet-due|
|Ongoing||2006-003746-42||Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma||not-yet-due|
|Ongoing||2006-003752-38||A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer||not-yet-due|
|Completed, but no date||2006-003775-13||A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer||bad-data|
|Ongoing||2006-004084-66||A phase II study on the efficacy and safety of topotecan in the treatment of patients with brain metastases||not-yet-due|
|Completed, but no date||2006-004751-38||Vaccine with dendritic cells pulsed tumoral cell line or with autologue tumor in patients with kidney carcinoma||bad-data|